Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model

Research in Veterinary Science

Volumn 86, Issue 2, 2009, Pages 241-247

  Huzella, Louis M ^a   Buckley, Marilyn J ^a   Alves, Derron A ^a   Stiles, Bradley G ^a   Krakauer, Teresa ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Chemokines; Cytokines; Mouse model; Staphylococcal enterotoxin B (SEB); Temperature

Indexed keywords

INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; STAPHYLOCOCCUS ENTEROTOXIN B; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOTHERMIA; INTOXICATION; LETHAL DOSE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN FUNCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-2; LUNG DISEASES; MICE; MICE, INBRED C3H; PILOT PROJECTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 60249090087     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.07.020     Document Type: Article

References (40)

1. Anderson T.D., Hayes T.J., Gately M.K., Bontempo J.M., Stern L.L., and Truitt G.A. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Separation of efficacy and toxicity by selective lymphocyte subset depletion. Laboratory Investigation 59 (1989) 598-612
2. Baluna R., and Vitetta E.S. Vascular leak syndrome, a side effect of immunotherapy. Immunopharmacology 37 (1997) 117-132
3. Bavari S., Ulrich R.G., and LeClaire R.D. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. Journal of Infectious Diseases 180 (1999) 1365-1369
4. Bean A.G., Freiberg R.A., Andrade S., Menon S., and Zlotnik A. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infection and Immunity 61 (1993) 4937-4939
5. Carr M.W., Roth S.J., Luther E., Rose S.S., and Springer T.A. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proceedings of the National Academy of Sciences (USA) 91 (1994) 3652-3656
6. Collins L.V., Eriksson K., Ulrich R.G., and Tarkowski A. Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infection and Immunity 70 (2002) 2282-2287
7. DaSilva L., Welcher B.C., Ulrich R.G., Aman M.J., David C.S., and Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. Journal of Infectious Diseases 185 (2002) 1754-1760
8. Deurenberg R.H., Vink C., Kalenic S., Friedrich A.W., Bruggeman C.A., and Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 13 (2007) 222-235
9. Hartings J.M., and Roy C.J. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. Journal of Pharmacological and Toxicological Methods 49 (2004) 39-55
10. Herz U., Ruckert R., Wollenhaupt K., Tschernig T., Neuhaus-Steinmetz U., Pabst R., and Renz H. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness - a model for non-allergic asthma. European Journal of Immunology 29 (1999) 1021-1031
11. Hopkins W., Gendron-Fitzpatrick A., McCarthy D.O., Haine J.E., and Uehling D.T. Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infection and Immunity 64 (1996) 1369-1372
12. Hornyak S.C., Orentas D.M., Karavodin L.M., and Gehlsen K.R. Histamine improves survival and protects against interleukin-2-induced pulmonary vascular leak syndrome in mice. Vascular Pharmacology 42 (2005) 187-193
13. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR-4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 162 (1999) 3749-3752
14. Ingalls R.R., Heine H., Lien E., Yoshimura D., and Golenbock D. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infectious Disease Clinics of North America 13 (1999) 341-353
15. Krakauer T. Stimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: cross-talk between pulmonary epithelial and peripheral blood mononuclear cells. Clinical and Diagnostic Laboratory Immunology 9 (2002) 126-131
16. Krakauer T., and Buckley M. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock. Antimicrobial Agents and Chemotherapy 50 (2006) 391-395
17. Krakauer T., and Stiles B.G. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release. Clinical and Diagnostic Laboratory Immunology 6 (1999) 594-598
18. Krakauer T., and Stiles B.G. Staphylococcal and streptococcal superantigens. In: Swearengen J.R. (Ed). Biodefense: Research Methodology and Animal Models (2006), CRC Press, Boca Raton 291-319
19. Li J., Gyorffy S., Lee S., and Kwok C.S. Effect of recombinant human interleukin-2 on neutrophil adherence to endothelial cells in vitro. Inflammation 20 (1996) 361-372
20. Little S.F., Ivins B.E., Webster W.M., Norris S.L.W., and Andrews G.P. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Vaccine 25 (2007) 2771-2777
21. Lyons C.R., Lovchik J., Hutt J., Lipscomb M.F., Wang E., Heninger S., Berliba L., and Garrison K. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infection and Immunity 72 (2004) 4801-4809
22. Madsen J.M. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clinics in Laboratory Medicine 21 (2001) 593-605
23. Massey R.C., Horsburgh M.J., Lina G., Hook M., and Recker M. The evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission?. Nature Reviews Microbiology 4 (2006) 953-958
24. Mattix M.E., Hunt R.E., Wilhelmsen C.L., Johnson A.J., and Baze W.B. Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys. Toxicologic Pathology 23 (1995) 262-268
25. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P.H., and Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. Journal of Experimental Medicine 175 (1992) 91-98
26. Migita K., and Ochi A. Induction of clonal anergy by oral administration of staphylococcal enterotoxin B. European Journal of Immunology 24 (1994) 2081-2086
27. Moet G.J., Jones R.N., Biedenbach D.J., Stilwell M.G., and Fritsche T.R. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998-2004). Diagnostic Microbiology and Infectious Disease 57 (2007) 7-13
28. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, D.C.
29. Rajagopalan G., Iijima K., Singh M., Kita H., Patel R., and David C.S. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infection and Immunity 74 (2006) 1284-1296
30. Roy C.J., Warfield K.L., Welcher B.C., Gonzales R.F., Larsen T., Hanson J., David C.S., Krakauer T., and Bavari S. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infection and Immunity 73 (2005) 2452-2460
31. Sarawar S.R., Blackman M.A., and Doherty P.C. Superantigen shock in mice with an inapparent viral infection. Journal of Infectious Diseases 170 (1994) 1189-1194
32. Savransky V., Rostaphshov V., Pinelis D., Polotsky Y., Korolev S., Komisar J., and Fegeding K. Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicologic Pathology 31 (2003) 373-378
33. Stiles B.G., Bavari S., Krakauer T., and Ulrich R.G. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infection and Immunity 61 (1993) 5333-5338
34. Stiles B.G., Campbell Y.G., Castle R.M., and Grove S.A. Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin-1. Infection and Immunity 67 (1999) 1521-1525
35. Stiles B.G., and Krakauer T. Staphylococcal enterotoxins: a purging experience in review. Clinical Microbiology Newsletter 27 23 (2005) 179-193
36. Sugiyama H., Bergdoll M.S., and Dack G.M. Early development of a temporary resistance to the emetic action of staphylococcal enterotoxin. Journal of Infectious Diseases 111 (1962) 233-238
37. Uchiyama T., Imanishi K., Miyoshi-Akiyama T., and Kato H. Staphylococcal superantigens and the diseases they cause. In: Alouf J.E., and Popoff M.R. (Eds). The Comprehensive Sourcebook of Bacterial Protein Toxins (2006), Academic Press, Amsterdam 830-843
38. Vlach K.D., Boles J.W., and Stiles B.G. Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock. Comparative Medicine 50 (2000) 160-166
39. Woody M.A., Krakauer T., and Stiles B.G. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model. Vaccine 15 (1997) 133-139
40. Woody M.A., Krakauer T., Ulrich R.G., and Stiles B.G. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. Journal of Infectious Diseases 177 (1998) 1013-1022